Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arich Enterprise CoROCO:4173 +0.28%67 3-Year ROIIC % is 4.24 as of Dec. 2025, which is 162% above its 10-year median of 1.62. GuruFocus rates ROCO:4173 with a GF Score™ of 67/100 and a GF Value™ of NT$29.06 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 619 Healthcare Providers & Services companies, Arich Enterprise Co ranks better than 51.53% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Arich Enterprise Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 4.24%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Arich Enterprise Co's 3-Year ROIIC % or its related term are showing as below:
ROCO:4173's 3-Year ROIIC % is ranked better than 51.53% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.48
vs ROCO:4173: 4.24
Arich Enterprise Co (ROCO:4173) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Arich Enterprise Co 3-Year ROIIC % Related Terms
Arich Enterprise Co 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Arich Enterprise Co's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arich Enterprise Co 3-Year ROIIC % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Arich Enterprise Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arich Enterprise Co 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Arich Enterprise Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Arich Enterprise Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Arich Enterprise Co (ROCO:4173) has a 3-Year ROIIC % of 4.24 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Arich Enterprise Co and its competitors. This is 162% above median its historical median of 1.62. According to the industry distribution chart, Arich Enterprise Co ranks #300 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 48.5%.
Is Arich Enterprise Co's 3-Year ROIIC % too high?
Arich Enterprise Co's current 3-Year ROIIC % of 4.24 is 162% above median its 10-year median of 1.62. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.48. Arich Enterprise Co's value of 4.24 is 21.8% above this industry median. Based on the distribution chart, Arich Enterprise Co ranks #300 out of 619 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Arich Enterprise Co has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arich Enterprise Co's 3-Year ROIIC % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Arich Enterprise Co ranks #300 out of 619 companies for 3-Year ROIIC %. This puts Arich Enterprise Co in the upper half of its industry. The industry median 3-Year ROIIC % is 3.48. Arich Enterprise Co's value of 4.24 is 21.8% above this benchmark. While the company's 10-year median is 1.62 vs. the industry median of 3.48, Arich Enterprise Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.48, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arich Enterprise Co's current 3-Year ROIIC % of 4.24 is 21.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Arich Enterprise Co and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arich Enterprise Co's current 3-Year ROIIC % is 4.24, which is 162% above median its own 10-year median of 1.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arich Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Arich Enterprise Co (ROCO:4173) is currently considered Possible Value Trap. The stock's GF Value™ is NT$29.06, compared to a current price of NT$17.70 — trading 39.1% below its estimated fair value. The current 3-Year ROIIC % is 4.24, which is 162% above median its 10-year median of 1.62 and 21.8% above the Healthcare Providers & Services industry median of 3.48. Arich Enterprise Co's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Arich Enterprise Co (ROCO:4173), the current 3-Year ROIIC % is 4.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arich Enterprise Co (ROCO:4173) Overvalued in 2026?
Based on GuruFocus' analysis, Arich Enterprise Co stock appears to be undervalued.
The current stock price of NT$17.70 is trading 39.1% below its estimated GF Value™ of NT$29.06.
GuruFocus considers Arich Enterprise Co to be Possible Value Trap.
Key valuation signals for ROCO:4173:
3-Year ROIIC %: 4.24 (162% above median its 10-year median of 1.62)
GF Value™: NT$29.06 vs. price of NT$17.70 (39.1% below fair value)
Industry Position: 21.8% above the Healthcare Providers & Services median (#300 of 619)
No single metric tells the full story. See the ROCO:4173 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arich Enterprise Co Ltd is a Taiwan-based company operating in the pharmaceutical industry. The company is engaged in providing medical sales promotion and logistics services. The company markets and sells pharmaceutical products. The company's services cover customers including medical centers, area hospitals, district hospitals, general practitioners, and key accounts which include chain stores and hypermarkets, drug stores, and wholesalers. The product portfolio includes Actos, Aftach, Cytotec, Gaster, Prometin, Hicee, Lederscon, Alinamin, Nacid tab, Setoral, Sibutil, and many more.
67GF Score
Get the complete analysis for ROCO:4173
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4173 has been successfully added to your 
